Correlation Between NeuroSense Therapeutics and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NeuroSense Therapeutics and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuroSense Therapeutics and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NeuroSense Therapeutics Ltd and Milestone Pharmaceuticals, you can compare the effects of market volatilities on NeuroSense Therapeutics and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuroSense Therapeutics with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuroSense Therapeutics and Milestone Pharmaceuticals.
Diversification Opportunities for NeuroSense Therapeutics and Milestone Pharmaceuticals
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between NeuroSense and Milestone is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding NeuroSense Therapeutics Ltd and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and NeuroSense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuroSense Therapeutics Ltd are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of NeuroSense Therapeutics i.e., NeuroSense Therapeutics and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between NeuroSense Therapeutics and Milestone Pharmaceuticals
Assuming the 90 days horizon NeuroSense Therapeutics Ltd is expected to generate 21.51 times more return on investment than Milestone Pharmaceuticals. However, NeuroSense Therapeutics is 21.51 times more volatile than Milestone Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Milestone Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 24.00 in NeuroSense Therapeutics Ltd on September 3, 2024 and sell it today you would earn a total of 0.00 from holding NeuroSense Therapeutics Ltd or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 72.53% |
| Values | Daily Returns |
NeuroSense Therapeutics Ltd vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| NeuroSense Therapeutics |
| Milestone Pharmaceuticals |
NeuroSense Therapeutics and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NeuroSense Therapeutics and Milestone Pharmaceuticals
The main advantage of trading using opposite NeuroSense Therapeutics and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuroSense Therapeutics position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| NeuroSense Therapeutics vs. DiaMedica Therapeutics | NeuroSense Therapeutics vs. Lyra Therapeutics | NeuroSense Therapeutics vs. Centessa Pharmaceuticals PLC |
| Milestone Pharmaceuticals vs. DiaMedica Therapeutics | Milestone Pharmaceuticals vs. Lyra Therapeutics | Milestone Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |